CISH, a novel intracellular immune checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints
Florencia Cano, Alberto Bravo‐Blas, Mathilde Colombé, Chiara Cerrato, Ram Venegalla, Olivier Preham, Ellie Burns, Paige M Mortimer, Nicholas J. Slipek, Matthew J. Johnson, Beau R. Webber, Branden S. Moriarity, Emil Lou, Modassir S. Choudhry, Christopher Austin Klebanoff, Tom Henley
This study shows that deleting CISH enhances T cell anti-cancer functions more than other intracellular checkpoints, improving tumor antigen recognition and killing in CAR-T cells.
bioRxiv · Apr 26, 2025 · PreprintCancer Biology